Neomed Institute
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private, Subsidiary
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neomed.ca
Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain
Phase 2
Completed
- Conditions
- PainOsteoarthritis of the Knee
- Interventions
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2017-03-13
- Lead Sponsor
- Neomed Institute
- Target Recruit Count
- 54
- Registration Number
- NCT02712957
- Locations
- 🇨🇦
Diex Recherche Montreal Inc, Montreal, Quebec, Canada
🇨🇦Algorithme Pharma, Montreal, Quebec, Canada
🇨🇦Diex Recherche Sherbrooke Inc, Sherbrooke, Quebec, Canada
NEO6860, a TRPV1 Antagonist, First in Human Study
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2016-03-10
- Lead Sponsor
- Neomed Institute
- Target Recruit Count
- 64
- Registration Number
- NCT02337543
- Locations
- 🇬🇧
Covance Cru, Leeds, United Kingdom
News
No news found